Referências Bibliográficas
Slamon, D. J., Gogolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. R.,
Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., and Press, M. F. (1989). Studies of the
HER-2/neu proto-oncogene in human breast and ovarian cancers. Science (Washington –
DC), v. 244, p. 707 – 712.
Smit, E. F., Groen, H. J., Splinter, T. A., Ebels, T., and Postmus, P. E. (1996). New
Sporn MB. (1976). Approaches to prevention of epithelial cancer during the
preneoplastic period. Cancer Res, v. 36(7 PT 2), p. 2699 – 2702.
Sreerama, Y. N., Gowda, L. R. (1998). Bowman-Birk type proteinase inhibitor
profile of horsegram (Dolichos biflorus) during germination and seed devolopment. J. Agri.
Food Chem., v. 46, p. 2596 – 2600.
St. Clair, W. H., Billings, P. C., Kennedy, A. R. (1990). The effects of the Bowman-
Birk protease inhibitor on c-myc expression and cell proliferation in the unirradiated and
irradiated mouse colon. Cancer Letters, v. 52, p. 145 – 152.
St. Clair, W., Billings, P., Carew, J., Keller-McGandy, C., Newbene, P. and
Kennedy, A. R. (1990). Suppression of DMHinduced carcinogenesis in mice by dietary
addition of the Bowman-Birk protease inhibitor. Cancer Res., v. 50, p. 580 – 586.
St. Clair, W., Billings, P.; Carew, J., Keller-McGandy, C., Newbene, P. and
Kennedy, A. R. (1991). Suppression of DMH induced carcinogenesis in mice by dietary
addition of the Bowman-Birk protease inhibitor. Cancer Res., v. 50, p. 580 – 586.
Tan, C.G.L., Stevens, F.C. (1971). Amino acids sequence of lima bean proteases
inhibitor component – IV: Isolation and sequence determination of tryptic peptides. Eur. J.
Biochem., v. 18, p. 515 – 523.
Tandon, A. K., Clark, G. M., Chamness, G. C., Ullrich, A., and McGuire, W. L.
(1989). HER-2/neu oncogene protein and prognosis in breast cancer. J. Clin. Oncol., v. 7, p.
1120 – 1128.
Tokunaga, A., Onda, M., Okuda, T., Teramoto, T., Fujita, I., Mizutani, T., Kiyama,
T., Yoshiyuki, T., Nishi, K., and Matsukura, N. (1995). Clinical significance of epidermal
growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer, v. 75, p. 1418 –
1425.
92